SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Best Manufacturing Stocks in India

Indias manufacturing sector covers diverse industries. Government initiatives aim to boost it as a global hub, fostering stock growth. Here is the list of top manufacturing stocks in India—your way to wealth in the countrys production cycle. Indias manufacturing sector covers diverse industries. Government initiatives aim to boost it as a global hub, fostering stock growth. Here is the list of top manufacturing stocks in India—your way to wealth in the countrys production cycle.

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen :- Q: Quality, V: Valuation, PT: Price Trend

Best Manufacturing Stocks in India as on Aug-2026 | 27 companies found

Filter

	Company Name	DeciZen	CMP	Price Change (%)	Market Cap (Cr)	52Week High	52Week Low	P/E	P/BV	EV/ EBITDA	5Y Profit Gr.(%)
1	Reliance Industries Ltd	Q V+ PT	1,307	1.00%	17,69,109 -	1,611 05 Jan, 26	1,251 24 Jul, 26	23.67	1.91	9.79	13.81	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Sun Pharmaceutical Industries Ltd	Q V+ PT	1,989	-0.57%	4,77,312 -	2,048 31 Jul, 26	1,547 26 Sep, 25	39.46	5.71	23.40	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	ITC Ltd	Q V+ PT	281	-1.51%	3,52,015 -	427 31 Oct, 25	275 04 Jun, 26	18.57	5.07	13.16	9.16	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Bajaj Auto Ltd	Q V+ PT	11,519	0.74%	3,16,559 -	11,589 31 Jul, 26	7,879 07 Aug, 25	26.92	8.74	19.55	17.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Tata Steel Ltd	Q V PT	190	1.52%	2,36,936 -	224 15 May, 26	153 01 Aug, 25	13.87	1.34	8.15	-0.60	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Hindalco Industries Ltd	Q V PT	974	0.37%	2,18,959 -	1,179 29 May, 26	657 12 Aug, 25	16.35	1.60	7.96	27.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Bosch Ltd	Q V PT	41,089	-1.04%	1,21,196 Mid Cap	42,950 23 Jul, 26	28,650 30 Mar, 26	43.75	8.16	34.47	19.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Bharat Forge Ltd	Q V+ PT	2,200	1.61%	1,05,191 Mid Cap	2,237 29 Jun, 26	1,101 29 Aug, 25	97.43	11.00	35.54	103.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Dr. Reddys Laboratories Ltd	Q V+ PT	1,148	0.28%	95,787 Mid Cap	1,414 29 Jun, 26	1,080 23 Jul, 26	29.73	2.51	15.26	15.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Dixon Technologies (India) Ltd	Q V+ PT	14,096	-1.68%	86,188 Mid Cap	18,472 25 Sep, 25	9,605 30 Mar, 26	69.42	26.61	55.15	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	UPL Ltd	Q V+ PT	604	0.41%	51,022 Mid Cap	812 02 Jan, 26	563 01 Jul, 26	26.55	1.47	6.72	-8.66	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	HFCL Ltd	Q V+ PT	194	5.00%	29,740 Small Cap	229 16 Jul, 26	59.83 23 Jan, 26	62.69	6.06	31.03	-5.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Amber Enterprises India Ltd	Q V PT	7,439	0.46%	26,236 Small Cap	8,970 07 May, 26	5,404 27 Jan, 26	179.86	8.57	45.97	-0.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	PG Electroplast Ltd	Q V+ PT	613	0.04%	17,583 Small Cap	816 01 Aug, 25	437 06 Apr, 26	142.17	6.56	86.10	71.18	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Minda Corporation Ltd	Q V+ PT	701	-0.94%	16,749 Small Cap	713 02 Jul, 26	445 11 Aug, 25	46.49	6.60	24.15	30.73	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Trident Ltd	Q V+ PT	24.72	0.08%	12,597 Small Cap	30.85 03 Feb, 26	22.00 17 Mar, 26	32.33	2.57	14.58	3.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Lumax Auto Technologies Ltd	Q V+ PT	1,567	3.40%	10,681 Small Cap	1,899 15 Apr, 26	955 08 Aug, 25	51.63	10.31	23.01	6.35	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Tejas Networks Ltd	Q V PT	514	1.10%	9,141 Small Cap	646 21 Aug, 25	294 27 Jan, 26	0.00	3.47	-21.24	-265.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Gokaldas Exports Ltd	Q V+ PT	815	1.34%	5,973 Small Cap	954 20 Nov, 25	532 27 Jan, 26	29.29	2.53	15.33	65.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	ADF Foods Ltd	Q V PT	271	2.75%	2,972 Small Cap	347 02 Jul, 26	154 30 Mar, 26	30.19	4.85	19.24	18.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Automotive Axles Ltd	Q V PT	1,803	0.17%	2,724 Small Cap	2,126 04 Feb, 26	1,536 02 Apr, 26	16.57	2.48	9.16	46.03	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	AYM Syntex Ltd	Q V+ PT	251	1.93%	1,474 Small Cap	280 02 Jul, 26	144 20 Jan, 26	224.71	2.50	15.85	-12.94	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Alicon Castalloy Ltd	Q V+ PT	669	-1.75%	1,098 Small Cap	1,025 27 Oct, 25	581 30 Mar, 26	33.41	1.92	7.14	13.81	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Monte Carlo Fashions Ltd	Q V+ PT	524	-0.59%	1,087 Small Cap	865 25 Nov, 25	465 30 Mar, 26	9.70	1.20	5.36	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	RSWM Ltd	Q V+ PT	211	0.26%	996 Small Cap	224 10 Jun, 26	120 30 Mar, 26	19.15	0.73	7.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Himatsingka Seide Ltd	Q V+ PT	79.13	-0.04%	995 Small Cap	139 01 Aug, 25	71.91 30 Mar, 26	16.06	0.46	6.13	23.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Ginni Filaments Ltd	Q V+ PT	45.26	-1.03%	388 Small Cap	57.89 06 Jul, 26	32.40 30 Mar, 26	10.99	1.58	6.48	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History

Investing in manufacturing stocks can offer several advantages:

Stability and Longevity: Manufacturing companies often have established track records and operate in essential industries, providing a stable investment environment.

Global Market Impact: Many manufacturing firms export their products, diversifying revenue streams and potentially mitigating risks associated with domestic market fluctuations.

Innovation and Technology: Manufacturing constantly evolves, embracing new technologies and innovations to enhance efficiency and reduce costs, potentially leading to increased profitability.

Infrastructure Development: As manufacturing expands, it often drives infrastructure development, benefiting not only the companies but also the regions they operate in.

Dividend Potential: Some manufacturing stocks offer consistent dividends, providing investors with regular income in addition to potential capital appreciation.

Economic Indicators: Manufacturing activity is often a key economic indicator. Growth in this sector can signify broader economic health, influencing stock performance positively.

Resilience to Economic Cycles: While sensitive to economic shifts, manufacturing can be resilient, as demand for certain products remains relatively constant even during economic downturns.

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

News about Best Manufacturing Stocks in India

Aug, 2026

HFCL informs about change in registered office

HFCL has informed that the Company has received the Certificate of Registration from the Registrar of Companies, Chandigarh, Haryana, on July 31, 2026, pursuant to the order passed by the Hon'ble Regional Director, Northern Region-II, Chandigarh on July 07, 2026, approving the shifting of the Registered Office of the Company from the State of Himachal Pradesh to the State of Haryana. A copy of the Certificate of Registration issued by the Registrar of Companies, Chandigarh, Haryana, is enclosed as Annexure-A. Accordingly, the Registered Office of the Company now stands shifted to the following address: HFCL Limited Plot No. 38, Institutional Area Sector -32, Gurugram-122 001 Haryana Consequent to the aforesaid change, Clause II of the Memorandum of Association of the Company has been altered in accordance with the provisions of the Companies Act, 2013. A copy of the amended Memorandum of Association is enclosed as Annexure-B.

The above information is a part of company’s filings submitted to BSE.

Aug, 2026

ITC reports 16% decline in Q1 consolidated net profit

Consolidated total income of the company increased by 26.74% to Rs 30,179.01 crore in Q1FY27

Aug, 2026

Dr. Reddy's Laboratories gets USFDA’s approval for rituximab biosimilar

The approval further strengthens its growing global biosimilars portfolio and advances its biosimilars business in the United States

Aug, 2026

Dr. Reddy’s Laboratories informs about press release

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release, ‘Dr. Reddy's Laboratories Receives U.S. FDA Approval for Rituximab Biosimilar’.

The above information is a part of company’s filings submitted to BSE.

Aug, 2026

ITC - Quaterly Results

The sales moved up 27.88% to Rs. 269432.30 millions for the June 2026 quarter as compared to Rs. 210698.10 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 35788.20 millions from Rs. 49107.30 millions ,decline by -27.12%.Operating Profit reported a sharp decline to 51596.70 millions from 69227.50 millions in the corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202606	202506	% Var	202606	202506	% Var	202603	202503	% Var
Sales	269432.30	210698.10	27.88	269432.30	210698.10	27.88	816401.10	742381.30	9.97
Other Income	6453.30	6620.30	-2.52	6453.30	6620.30	-2.52	32871.80	34549.70	-4.86
PBIDT	51596.70	69227.50	-25.47	51596.70	69227.50	-25.47	284954.00	274805.80	3.69
Interest	337.80	134.00	152.09	337.80	134.00	152.09	699.40	363.50	92.41
PBDT	51258.90	69093.50	-25.81	51258.90	69093.50	-25.81	282415.90	279721.90	0.96
Depreciation	3664.80	3658.70	0.17	3664.80	3658.70	0.17	14739.90	14419.30	2.22
PBT	47594.10	65434.80	-27.26	47594.10	65434.80	-27.26	267676.00	265302.60	0.89
TAX	11805.90	16327.50	-27.69	11805.90	16327.50	-27.69	64811.80	64369.70	0.69
Deferred Tax	-7.00	547.90	-101.28	-7.00	547.90	-101.28	6590.20	4468.00	47.50
PAT	35788.20	49107.30	-27.12	35788.20	49107.30	-27.12	202864.20	200932.90	0.96
Equity	12529.50	12517.50	0.10	12529.50	12517.50	0.10	12529.50	12514.10	0.12
PBIDTM(%)	19.15	32.86	-41.72	19.15	32.86	-41.72	34.90	37.02	-5.71

Aug, 2026

Sun Pharma. Inds. - Quaterly Results

The company's total revenue for the quarter ended June 2026 saw a slight change in the total revenue, having registered a total revenue of Rs. 57411.30 millions.A comparatively good net profit growth of 49.67% to Rs. 11151.40 millions was reported for the quarter ended June 2026 compared to Rs. 7450.60 millions of previous same quarter.Operating profit surged to 21043.80 millions from the corresponding previous quarter of 20132.40 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202606	202506	% Var	202606	202506	% Var	202603	202503	% Var
Sales	57411.30	55948.80	2.61	57411.30	55948.80	2.61	207546.40	229774.00	-9.67
Other Income	1401.70	1037.10	35.16	1401.70	1037.10	35.16	4193.30	3791.40	10.60
PBIDT	21043.80	20132.40	4.53	21043.80	20132.40	4.53	66000.20	72168.40	-8.55
Interest	2784.80	2384.20	16.80	2784.80	2384.20	16.80	9478.40	9538.90	-0.63
PBDT	17943.70	14871.80	20.66	17943.70	14871.80	20.66	51058.40	62629.50	-18.48
Depreciation	3079.20	3109.20	-0.96	3079.20	3109.20	-0.96	13117.20	12867.40	1.94
PBT	14864.50	11762.60	26.37	14864.50	11762.60	26.37	37941.20	49762.10	-23.75
TAX	3713.10	4312.00	-13.89	3713.10	4312.00	-13.89	11707.00	7481.30	56.48
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	11151.40	7450.60	49.67	11151.40	7450.60	49.67	26234.20	42280.80	-37.95
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	36.65	35.98	1.86	36.65	35.98	1.86	31.80	31.41	1.25

Track Now:

5 Star Companies Large Cap Companies Mid Cap Companies Small Cap Companies Nifty Microcap Companies Top IT Companies Tax saver funds Analyze your Equity Funds Nifty Index Funds

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Best Manufacturing Stocks in India

News about Best Manufacturing Stocks in India

HFCL informs about change in registered office

ITC reports 16% decline in Q1 consolidated net profit

Dr. Reddy's Laboratories gets USFDA’s approval for rituximab biosimilar

Dr. Reddy’s Laboratories informs about press release

ITC - Quaterly Results

Sun Pharma. Inds. - Quaterly Results

Track Now:

Trending Blogs

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.